Cargando…
Application of Dendrimers for Treating Parasitic Diseases
Despite advances in medical knowledge, parasitic diseases remain a significant global health burden and their pharmacological treatment is often hampered by drug toxicity. Therefore, drug delivery systems may provide useful advantages when used in combination with conventional therapeutic compounds....
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998910/ https://www.ncbi.nlm.nih.gov/pubmed/33808016 http://dx.doi.org/10.3390/pharmaceutics13030343 |
_version_ | 1783670660779737088 |
---|---|
author | Folliero, Veronica Zannella, Carla Chianese, Annalisa Stelitano, Debora Ambrosino, Annalisa De Filippis, Anna Galdiero, Marilena Franci, Gianluigi Galdiero, Massimiliano |
author_facet | Folliero, Veronica Zannella, Carla Chianese, Annalisa Stelitano, Debora Ambrosino, Annalisa De Filippis, Anna Galdiero, Marilena Franci, Gianluigi Galdiero, Massimiliano |
author_sort | Folliero, Veronica |
collection | PubMed |
description | Despite advances in medical knowledge, parasitic diseases remain a significant global health burden and their pharmacological treatment is often hampered by drug toxicity. Therefore, drug delivery systems may provide useful advantages when used in combination with conventional therapeutic compounds. Dendrimers are three-dimensional polymeric structures, characterized by a central core, branches and terminal functional groups. These nanostructures are known for their defined structure, great water solubility, biocompatibility and high encapsulation ability against a wide range of molecules. Furthermore, the high ratio between terminal groups and molecular volume render them a hopeful vector for drug delivery. These nanostructures offer several advantages compared to conventional drugs for the treatment of parasitic infection. Dendrimers deliver drugs to target sites with reduced dosage, solving side effects that occur with accepted marketed drugs. In recent years, extensive progress has been made towards the use of dendrimers for therapeutic, prophylactic and diagnostic purposes for the management of parasitic infections. The present review highlights the potential of several dendrimers in the management of parasitic diseases. |
format | Online Article Text |
id | pubmed-7998910 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79989102021-03-28 Application of Dendrimers for Treating Parasitic Diseases Folliero, Veronica Zannella, Carla Chianese, Annalisa Stelitano, Debora Ambrosino, Annalisa De Filippis, Anna Galdiero, Marilena Franci, Gianluigi Galdiero, Massimiliano Pharmaceutics Review Despite advances in medical knowledge, parasitic diseases remain a significant global health burden and their pharmacological treatment is often hampered by drug toxicity. Therefore, drug delivery systems may provide useful advantages when used in combination with conventional therapeutic compounds. Dendrimers are three-dimensional polymeric structures, characterized by a central core, branches and terminal functional groups. These nanostructures are known for their defined structure, great water solubility, biocompatibility and high encapsulation ability against a wide range of molecules. Furthermore, the high ratio between terminal groups and molecular volume render them a hopeful vector for drug delivery. These nanostructures offer several advantages compared to conventional drugs for the treatment of parasitic infection. Dendrimers deliver drugs to target sites with reduced dosage, solving side effects that occur with accepted marketed drugs. In recent years, extensive progress has been made towards the use of dendrimers for therapeutic, prophylactic and diagnostic purposes for the management of parasitic infections. The present review highlights the potential of several dendrimers in the management of parasitic diseases. MDPI 2021-03-05 /pmc/articles/PMC7998910/ /pubmed/33808016 http://dx.doi.org/10.3390/pharmaceutics13030343 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Review Folliero, Veronica Zannella, Carla Chianese, Annalisa Stelitano, Debora Ambrosino, Annalisa De Filippis, Anna Galdiero, Marilena Franci, Gianluigi Galdiero, Massimiliano Application of Dendrimers for Treating Parasitic Diseases |
title | Application of Dendrimers for Treating Parasitic Diseases |
title_full | Application of Dendrimers for Treating Parasitic Diseases |
title_fullStr | Application of Dendrimers for Treating Parasitic Diseases |
title_full_unstemmed | Application of Dendrimers for Treating Parasitic Diseases |
title_short | Application of Dendrimers for Treating Parasitic Diseases |
title_sort | application of dendrimers for treating parasitic diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998910/ https://www.ncbi.nlm.nih.gov/pubmed/33808016 http://dx.doi.org/10.3390/pharmaceutics13030343 |
work_keys_str_mv | AT follieroveronica applicationofdendrimersfortreatingparasiticdiseases AT zannellacarla applicationofdendrimersfortreatingparasiticdiseases AT chianeseannalisa applicationofdendrimersfortreatingparasiticdiseases AT stelitanodebora applicationofdendrimersfortreatingparasiticdiseases AT ambrosinoannalisa applicationofdendrimersfortreatingparasiticdiseases AT defilippisanna applicationofdendrimersfortreatingparasiticdiseases AT galdieromarilena applicationofdendrimersfortreatingparasiticdiseases AT francigianluigi applicationofdendrimersfortreatingparasiticdiseases AT galdieromassimiliano applicationofdendrimersfortreatingparasiticdiseases |